IBDEI06S ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8482,2)
 ;;=^5063739
 ;;^UTILITY(U,$J,358.3,8483,0)
 ;;=H04.123^^31^458^8
 ;;^UTILITY(U,$J,358.3,8483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8483,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,8483,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,8483,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,8484,0)
 ;;=H01.009^^31^458^9
 ;;^UTILITY(U,$J,358.3,8484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8484,1,3,0)
 ;;=3^Blepharitis,Unspec
 ;;^UTILITY(U,$J,358.3,8484,1,4,0)
 ;;=4^H01.009
 ;;^UTILITY(U,$J,358.3,8484,2)
 ;;=^5133381
 ;;^UTILITY(U,$J,358.3,8485,0)
 ;;=H40.023^^31^458^10
 ;;^UTILITY(U,$J,358.3,8485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8485,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,High Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,8485,1,4,0)
 ;;=4^H40.023
 ;;^UTILITY(U,$J,358.3,8485,2)
 ;;=^5005730
 ;;^UTILITY(U,$J,358.3,8486,0)
 ;;=H40.053^^31^458^11
 ;;^UTILITY(U,$J,358.3,8486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8486,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,8486,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,8486,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,8487,0)
 ;;=H40.11X3^^31^458^12
 ;;^UTILITY(U,$J,358.3,8487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8487,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,8487,1,4,0)
 ;;=4^H40.11X3
 ;;^UTILITY(U,$J,358.3,8487,2)
 ;;=^5005756
 ;;^UTILITY(U,$J,358.3,8488,0)
 ;;=H35.31^^31^458^13
 ;;^UTILITY(U,$J,358.3,8488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8488,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,8488,1,4,0)
 ;;=4^H35.31
 ;;^UTILITY(U,$J,358.3,8488,2)
 ;;=^5005647
 ;;^UTILITY(U,$J,358.3,8489,0)
 ;;=H35.32^^31^458^14
 ;;^UTILITY(U,$J,358.3,8489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8489,1,3,0)
 ;;=3^Exudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,8489,1,4,0)
 ;;=4^H35.32
 ;;^UTILITY(U,$J,358.3,8489,2)
 ;;=^5005648
 ;;^UTILITY(U,$J,358.3,8490,0)
 ;;=E11.9^^31^458^15
 ;;^UTILITY(U,$J,358.3,8490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8490,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,8490,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,8490,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,8491,0)
 ;;=E11.39^^31^458^16
 ;;^UTILITY(U,$J,358.3,8491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8491,1,3,0)
 ;;=3^DM Type 2 w/ Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,8491,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,8491,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,8492,0)
 ;;=E11.329^^31^458^17
 ;;^UTILITY(U,$J,358.3,8492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8492,1,3,0)
 ;;=3^DM Type 2 w/ Mild NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,8492,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,8492,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,8493,0)
 ;;=E11.339^^31^458^18
 ;;^UTILITY(U,$J,358.3,8493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8493,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,8493,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,8493,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,8494,0)
 ;;=H59.039^^31^458^19
 ;;^UTILITY(U,$J,358.3,8494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8494,1,3,0)
 ;;=3^CME Mac Edema,Unspec Eye
 ;;^UTILITY(U,$J,358.3,8494,1,4,0)
 ;;=4^H59.039
 ;;^UTILITY(U,$J,358.3,8494,2)
 ;;=^5006396
 ;;^UTILITY(U,$J,358.3,8495,0)
 ;;=H43.391^^31^458^20
 ;;^UTILITY(U,$J,358.3,8495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8495,1,3,0)
 ;;=3^Vitreous Opacities,Right Eye NEC
 ;;^UTILITY(U,$J,358.3,8495,1,4,0)
 ;;=4^H43.391
 ;;^UTILITY(U,$J,358.3,8495,2)
 ;;=^5005949
 ;;^UTILITY(U,$J,358.3,8496,0)
 ;;=H43.392^^31^458^21
 ;;^UTILITY(U,$J,358.3,8496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8496,1,3,0)
 ;;=3^Vitreous Opacities,Left Eye NEC
 ;;^UTILITY(U,$J,358.3,8496,1,4,0)
 ;;=4^H43.392
 ;;^UTILITY(U,$J,358.3,8496,2)
 ;;=^5005950
 ;;^UTILITY(U,$J,358.3,8497,0)
 ;;=H02.831^^31^458^22
 ;;^UTILITY(U,$J,358.3,8497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8497,1,3,0)
 ;;=3^Dermatochalasis,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,8497,1,4,0)
 ;;=4^H02.831
 ;;^UTILITY(U,$J,358.3,8497,2)
 ;;=^5004418
 ;;^UTILITY(U,$J,358.3,8498,0)
 ;;=H02.834^^31^458^23
 ;;^UTILITY(U,$J,358.3,8498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8498,1,3,0)
 ;;=3^Dermatochalasis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,8498,1,4,0)
 ;;=4^H02.834
 ;;^UTILITY(U,$J,358.3,8498,2)
 ;;=^5004421
 ;;^UTILITY(U,$J,358.3,8499,0)
 ;;=H10.31^^31^458^24
 ;;^UTILITY(U,$J,358.3,8499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8499,1,3,0)
 ;;=3^Conjunctivitis,Acute,Right Eye
 ;;^UTILITY(U,$J,358.3,8499,1,4,0)
 ;;=4^H10.31
 ;;^UTILITY(U,$J,358.3,8499,2)
 ;;=^5133458
 ;;^UTILITY(U,$J,358.3,8500,0)
 ;;=H10.32^^31^458^25
 ;;^UTILITY(U,$J,358.3,8500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8500,1,3,0)
 ;;=3^Conjunctivitis,Acute,Left Eye
 ;;^UTILITY(U,$J,358.3,8500,1,4,0)
 ;;=4^H10.32
 ;;^UTILITY(U,$J,358.3,8500,2)
 ;;=^5133459
 ;;^UTILITY(U,$J,358.3,8501,0)
 ;;=H00.11^^31^458^26
 ;;^UTILITY(U,$J,358.3,8501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8501,1,3,0)
 ;;=3^Chalazion,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,8501,1,4,0)
 ;;=4^H00.11
 ;;^UTILITY(U,$J,358.3,8501,2)
 ;;=^5004233
 ;;^UTILITY(U,$J,358.3,8502,0)
 ;;=H00.14^^31^458^27
 ;;^UTILITY(U,$J,358.3,8502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8502,1,3,0)
 ;;=3^Chalazion,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,8502,1,4,0)
 ;;=4^H00.14
 ;;^UTILITY(U,$J,358.3,8502,2)
 ;;=^5004236
 ;;^UTILITY(U,$J,358.3,8503,0)
 ;;=H20.00^^31^458^28
 ;;^UTILITY(U,$J,358.3,8503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8503,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,8503,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,8503,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,8504,0)
 ;;=B00.59^^31^458^29
 ;;^UTILITY(U,$J,358.3,8504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8504,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,8504,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,8504,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,8505,0)
 ;;=Z01.00^^31^458^30
 ;;^UTILITY(U,$J,358.3,8505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8505,1,3,0)
 ;;=3^Eye/Vision Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,8505,1,4,0)
 ;;=4^Z01.00
 ;;^UTILITY(U,$J,358.3,8505,2)
 ;;=^5062612
 ;;^UTILITY(U,$J,358.3,8506,0)
 ;;=Z01.01^^31^458^31
 ;;^UTILITY(U,$J,358.3,8506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8506,1,3,0)
 ;;=3^Eye/Vision Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,8506,1,4,0)
 ;;=4^Z01.01
 ;;^UTILITY(U,$J,358.3,8506,2)
 ;;=^5062613
 ;;^UTILITY(U,$J,358.3,8507,0)
 ;;=H10.31^^31^459^1
 ;;^UTILITY(U,$J,358.3,8507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8507,1,3,0)
 ;;=3^Conjunctivitis,Acute,Right Eye
 ;;^UTILITY(U,$J,358.3,8507,1,4,0)
 ;;=4^H10.31
 ;;^UTILITY(U,$J,358.3,8507,2)
 ;;=^5133458
 ;;^UTILITY(U,$J,358.3,8508,0)
 ;;=H10.32^^31^459^2
 ;;^UTILITY(U,$J,358.3,8508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8508,1,3,0)
 ;;=3^Conjunctivitis,Acute,Left Eye
 ;;^UTILITY(U,$J,358.3,8508,1,4,0)
 ;;=4^H10.32
 ;;^UTILITY(U,$J,358.3,8508,2)
 ;;=^5133459
 ;;^UTILITY(U,$J,358.3,8509,0)
 ;;=H10.401^^31^459^3
 ;;^UTILITY(U,$J,358.3,8509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8509,1,3,0)
 ;;=3^Conjunctivitis,Chronic,Right Eye
 ;;^UTILITY(U,$J,358.3,8509,1,4,0)
 ;;=4^H10.401
 ;;^UTILITY(U,$J,358.3,8509,2)
 ;;=^5004681
 ;;^UTILITY(U,$J,358.3,8510,0)
 ;;=H10.402^^31^459^4
 ;;^UTILITY(U,$J,358.3,8510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8510,1,3,0)
 ;;=3^Conjunctivitis,Chronic,Left Eye
 ;;^UTILITY(U,$J,358.3,8510,1,4,0)
 ;;=4^H10.402
 ;;^UTILITY(U,$J,358.3,8510,2)
 ;;=^5004682
 ;;^UTILITY(U,$J,358.3,8511,0)
 ;;=H10.403^^31^459^5
 ;;^UTILITY(U,$J,358.3,8511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8511,1,3,0)
 ;;=3^Conjunctivitis,Chronic,Bilateral
 ;;^UTILITY(U,$J,358.3,8511,1,4,0)
 ;;=4^H10.403
 ;;^UTILITY(U,$J,358.3,8511,2)
 ;;=^5004683
 ;;^UTILITY(U,$J,358.3,8512,0)
 ;;=H10.45^^31^459^6
 ;;^UTILITY(U,$J,358.3,8512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8512,1,3,0)
 ;;=3^Conjunctivitis,Allergic,Chronic
 ;;^UTILITY(U,$J,358.3,8512,1,4,0)
 ;;=4^H10.45
 ;;^UTILITY(U,$J,358.3,8512,2)
 ;;=^87396
 ;;^UTILITY(U,$J,358.3,8513,0)
 ;;=B30.8^^31^459^7
 ;;^UTILITY(U,$J,358.3,8513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8513,1,3,0)
 ;;=3^Conjunctivitis,Viral
 ;;^UTILITY(U,$J,358.3,8513,1,4,0)
 ;;=4^B30.8
 ;;^UTILITY(U,$J,358.3,8513,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,8514,0)
 ;;=H10.13^^31^459^8
 ;;^UTILITY(U,$J,358.3,8514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8514,1,3,0)
 ;;=3^Conjunctivitis,Atopic,Bilateral
 ;;^UTILITY(U,$J,358.3,8514,1,4,0)
 ;;=4^H10.13
 ;;^UTILITY(U,$J,358.3,8514,2)
 ;;=^5004667
 ;;^UTILITY(U,$J,358.3,8515,0)
 ;;=H10.419^^31^459^9
 ;;^UTILITY(U,$J,358.3,8515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8515,1,3,0)
 ;;=3^Giant Papillary Conjunctivitis,Chronic
 ;;^UTILITY(U,$J,358.3,8515,1,4,0)
 ;;=4^H10.419
 ;;^UTILITY(U,$J,358.3,8515,2)
 ;;=^5004687
 ;;^UTILITY(U,$J,358.3,8516,0)
 ;;=H10.219^^31^459^10
 ;;^UTILITY(U,$J,358.3,8516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8516,1,3,0)
 ;;=3^Toxic Conjunctivitis,Acute
 ;;^UTILITY(U,$J,358.3,8516,1,4,0)
 ;;=4^H10.219
 ;;^UTILITY(U,$J,358.3,8516,2)
 ;;=^5004671
 ;;^UTILITY(U,$J,358.3,8517,0)
 ;;=M35.01^^31^459^11
 ;;^UTILITY(U,$J,358.3,8517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8517,1,3,0)
 ;;=3^Keratoconjunctivitis w/ Sicca Syndrome
 ;;^UTILITY(U,$J,358.3,8517,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,8517,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,8518,0)
 ;;=H11.31^^31^459^12
 ;;^UTILITY(U,$J,358.3,8518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8518,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,8518,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,8518,2)
 ;;=^5004782
